Correlation Between Teva Pharma and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Teva Pharma Industries and Neurocrine Biosciences, you can compare the effects of market volatilities on Teva Pharma and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Neurocrine Biosciences.

Diversification Opportunities for Teva Pharma and Neurocrine Biosciences

0.61

Correlation Coefficient

Teva Pharma  Neurocrine Biosciences

Poor diversification

The 3 months correlation between Teva and Neurocrine is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Teva Pharma i.e., Teva Pharma and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between Teva Pharma and Neurocrine Biosciences

Given the investment horizon of 90 days Teva Pharma Industries is expected to generate 1.53 times more return on investment than Neurocrine Biosciences. However, Teva Pharma is 1.53 times more volatile than Neurocrine Biosciences. It trades about 0.02 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about -0.03 per unit of risk. If you would invest  1,678  in Teva Pharma Industries on November 28, 2024 and sell it today you would lose (13.00) from holding Teva Pharma Industries or give up 0.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Teva Pharma Industries  vs.  Neurocrine Biosciences

Teva Pharma Industries

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharma Industries are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Teva Pharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Neurocrine Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Neurocrine Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Teva Pharma and Neurocrine Biosciences

The main advantage of trading using opposite Teva Pharma and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind Teva Pharma Industries and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.